Two novel (M233T and R278T) presenilin-1 mutations in early-onset Alzheimer's disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotype

Neuroreport
J B KwokR N Martins

Abstract

Eleven early-onset dementia families, all with affected individuals who have either presented clinical symptoms of early onset familial Alzheimer's disease (EOFAD) or have been confirmed to have EOFAD by autopsy, and two early onset cases with biopsy-confirmed AD pathology, were screened for missense mutations in the entire coding region of presenilin-1 (PS-1) and -2 (PS-2) genes. Missense mutations were detected by direct sequence analysis of PCR products amplified from genomic DNA templates of affected individuals. Three pedigrees were attributable to known mutations in the PS-1 gene: P264L, E280A and the splice acceptor site (G to T) mutation, which results in the deletion of residues 290-319 of PS-1 (PS-1 delta 290-319). In a fourth pedigree, a novel PS-1 mutation was identified in exon 7 (M233T), which is homologous to a pathogenic PS-2 mutation (M239V), and is characterized by a very early average age of onset (before the age of 35). In one early onset case, another novel PS-1 mutation was identified in exon 8 (R278T). Of the five remaining families and the other early onset case, none have missense mutations in the PS-1 or PS-2 genes, or in exon 16 and 17 of the APP gene. Moreover, two of the PS-1 mutations, PS-1 delta 2...Continue Reading

References

Nov 1, 1995·Nature Genetics·C Van Broeckhoven
Mar 1, 1995·Annals of Neurology·S G Younkin

❮ Previous
Next ❯

Citations

Feb 24, 2001·Annals of Neurology·M J SmithW S Brooks
Sep 25, 2004·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Dimitrios AvramopoulosSusan S Bassett
Oct 23, 2002·Journal of Neuroscience Research·Takeshi TabiraMakoto Shibuya
Aug 23, 2005·Brain Research. Brain Research Reviews·Emilio Fernandez-EspejoSusana Ramiro
Feb 5, 2004·Journal of the Neurological Sciences·Auli VerkkoniemiMatti Haltia
Jan 31, 2004·Neurobiology of Disease·Claire E ShepherdGlenda M Halliday
May 17, 2005·Neurobiology of Aging·Gillian C GregoryGlenda M Halliday
Sep 29, 1999·Journal of the Neurological Sciences·W C KollerA Albanese
Jul 25, 2000·Psychiatry Research·K OharaK Ohara
Aug 1, 2000·Brain Research. Developmental Brain Research·T ZigovaP R Sanberg
Dec 25, 2002·Neurobiology of Aging·P H KellyB Sommer
Feb 12, 2000·Progress in Neurobiology·C CzechL Pradier
Mar 14, 2000·Neuroscience Letters·S SongH Takahashi
Dec 19, 1998·Molecular Medicine Today·A E WillingP R Sanberg
May 30, 2001·Drug Discovery Today·R A. Barker, A E. Rosser
Feb 5, 2010·Lancet Neurology·Bruno A Bergmans, Bart De Strooper
Apr 18, 1998·Nature Medicine·B A Yankner
Oct 13, 2000·The European Journal of Neuroscience·S A PrzyborskiP W Andrews
Apr 26, 2002·Neuroreport·Gerald MünchGlenda M Halliday
Sep 10, 2002·Alzheimer Disease and Associated Disorders·Guilian XuDavid R Borchelt
Dec 2, 2009·Alzheimer Disease and Associated Disorders·William D KnightMartin N Rossor
Sep 12, 2007·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Christopher M FilleyBernardino Ghetti
Jun 28, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·W D KnightC Mummery
Feb 3, 1999·Annual Review of Genetics·D L PriceS S Sisodia
May 11, 2012·Dementia and Geriatric Cognitive Disorders·Takanori IshizukaAkira Sano
Jan 4, 2003·The Journal of Clinical Investigation·Todd E Golde
Jul 23, 2013·Translational Neurodegeneration·Shuting ZhangWeihong Song
Jul 31, 1998·Reviews in the Neurosciences·P L McGeerE G McGeer
Jun 29, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Orly LazarovSangram S Sisodia
May 4, 2006·The Journal of Clinical Psychiatry·Andreas PapassotiropoulosEric M Reiman
Apr 15, 2014·Clinical Interventions in Aging·Eva BagyinszkySangYun Kim

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.